Targeting Drug Costs Will Have Minimal Impact On Federal Health Care Spending - Avalere
This article was originally published in The Pink Sheet Daily
Executive Summary
Recent analysis shows that only about 8% of federal Medicare and Medicaid spending goes to brand-name prescription drugs.